Citation Impact
Citing Papers
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
1997
Heparin-Protein Interactions
2002 Standout
Discovery of archaeal fusexins homologous to eukaryotic HAP2/GCS1 gamete fusion proteins
2022 StandoutNobel
Macaques Infected with Live Attenuated SIVmac Are Protected against Superinfection via the Rectal Mucosa
1997
Inflammation and cancer
2002 StandoutNature
Immunization with Tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection
1992
Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus
2002
Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys
2003
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2
1990
Current assessment of yellow fever and yellow fever vaccine
2004
Structure of the dengue virus envelope protein after membrane fusion
2004 Nature
Atomic structure of the ectodomain from HIV-1 gp41
1997 StandoutNature
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Human Studies in the Development of Human Immunodeficiency Virus Vaccines
1995
Structure of Dengue Virus
2002 Standout
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys
1991 Nature
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
1995 StandoutNature
Pre-eclampsia
2005 Standout
HIV with Multiple Gene Deletions as a Live Attenuated Vaccine for AIDS
1992
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women
1999
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Poliovirus and poliomyelitis: A tale of guts, brains, and an accidental event
2005
A Blueprint for HIV Vaccine Discovery
2012
Structural and functional diversity of viral IRESes
2009
Dengue
2012 Standout
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases
2001
The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
2002
Phenotypic and Molecular Analyses of Yellow Fever 17DD Vaccine Viruses Associated with Serious Adverse Events in Brazil
2001
Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination
1993
Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone
1991
Coxsackievirus B3 clinical isolates and murine myocarditis
1996
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Myocarditis
2009 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection
2004
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
2003 StandoutNobel
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.
1994
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.
1992
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.
1992
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA
1997 StandoutNobel
Requirements at the 3′ End of the Sindbis Virus Genome for Efficient Synthesis of Minus-Strand RNA
2005 StandoutNobel
Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles
2002 StandoutNobel
Yellow fever vaccine
2005
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
A Single Nucleotide Change in the 5′ Noncoding Region of Sindbis Virus Confers Neurovirulence in Rats
1999 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene
1992 Science
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge
1994
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.
1992 StandoutNobel
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties
1999 StandoutNobel
A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence
1992
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Attenuating mutations in glycoproteins E1 and E2 of Sindbis virus produce a highly attenuated strain when combined in vitro
1990
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
The Trojan exosome hypothesis
2003
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106
2008
GENETICS OF POLIOVIRUS
1993
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA
1996 StandoutNobel
Preventives Versus Treatments *
2015 StandoutNobel
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines
1994
The Decreased Replicative Capacity of Simian Immunodeficiency Virus SIVmac239ΔnefIs Manifest in Cultures of Immature Dendritic Cells and T Cells
2000 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
The Simian Immunodeficiency Virus ΔnefVaccine, after Application to the Tonsils of Rhesus Macaques, Replicates Primarily within CD4+T Cells and Elicits a Local Perforin-Positive CD8+T-Cell Response
2002 StandoutNobel
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection
1993
Impact of Viral Factors on Very Early In Vivo Replication Profiles in Simian Immunodeficiency Virus SIVagm-Infected African Green Monkeys
2005 StandoutNobel
Works of F. Taffs being referenced
Reversion of the attenuated and temperature-sensitive phenotypes of the sabin type 3 strain of poliovirus in vaccinees
1989
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine
1990
Analysis of a Yellow Fever Virus Isolated from a Fatal Case of Vaccine-Associated Human Encephalitis
1994
Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine
1995
Passive Immunization of Cynomolgus Macaques with Immune Sera or a Pool of Neutralizing Monoclonal Antibodies Failed to Protect Against Challenge with SIVmac251
1994
Vaccine Studies With the 32 H Reisolate of SIV mac251 : An Overview
1992
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response.
1992
Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity
1991
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
1989